0069-1014 : Bosulif 100 mg Oral Capsule


NDC: 0069-1014
Labeler: Pfizer Laboratories Div Pfizer Inc
Product Type: Human Prescription Drug
Drug Name:  Bosulif
Dosage Form: Oral Capsule
Application #: NDA217729
Rev. Date: 


NDC Package Codes:

  • 0069-1014-15: 150 CAPSULE IN 1 BOTTLE (0069‑1014‑15)

Active Ingredients:

  • Bosutinib Monohydrate

Dosage Strength:

  • 100 mg

Pharmaceutical Classes:

  • Bcr-Abl Tyrosine Kinase Inhibitors [MoA]
  • Kinase Inhibitor [EPC]

Related Products:

Based on records with the same trade name.
  • 0069-0135 Bosulif 100 mg Oral Tablet by Pfizer Laboratories Div Pfizer Inc
  • 0069-0136 Bosulif 500 mg Oral Tablet by Pfizer Laboratories Div Pfizer Inc
  • 0069-0193 Bosulif 400 mg Oral Tablet, Film Coated by Pfizer Laboratories Div Pfizer Inc
  • 0069-0504 Bosulif 50 mg Oral Capsule by Pfizer Laboratories Div Pfizer Inc
  • 63539-117 Bosulif 100 mg Oral Tablet, Film Coated by U.S. Pharmaceuticals
  • 63539-193 Bosulif 400 mg Oral Tablet, Film Coated by U.S. Pharmaceuticals

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 0069-1014 QR Code

< Prev: 0069-1011Next: 0069-1029 >

Related Discussions:

chest pain while taking bosulif
I have been taking bosulif for a little over a year now. I first started with 300 mg with very few side effects. About 1... 1 reply
Patient assistance income guidelines for Bosulif
Does anyone know the income guidelines for the patient assistance program for Bosulif? ## @Jake, Interestingly enough, P... 1 reply




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.